BioChemAnalysis Corp. Report issue

For profit Phase 1
Founded: Chicago IL United States (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2006
NCT00399191
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

dysprosium (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 1)

Anemia, Iron-Deficiency (Phase 1)

Deficiency Diseases (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1